Skip Nav Destination
Issues
1 October 2008
-
Cover Image
Cover Image
Immunocytochemistry and confocal microscopy of parental CCRF-CEM and 2ME2-resistant leukemia cells demonstrating differences in their microtubule networks. Parental CCRF-CEM (A) and CEM/2ME2-28.8R (B) cells were cytospun onto glass slides and double-immunofluorescent detection performed for α-tubulin (green, panel ii) and acetylated α-tubulin (red, panel iii). Channels for α-tubulin and acetylated α-tubulin were overlayed and demonstrate that 2ME2-resistant cells (B, panel iii) have a denser microtubule network compared to parental cells (A, panel iii). Scale bar, represents 10 μm (B, panel iv). Location of four β-tubulin mutated residues, Asn25, Asn197, Thr248, and Asn350 in the αβ-tubulin heterodimer relative to the known colchicine-binding site identified in 2ME2-resistant leukemia cells. The locations of the mutated residues are shown in green. Blue and orange ribbons represent β- and α-tubulin, respectively. Thr248 and Asn350 mutations are situated in close proximity to the colchicine-binding site whereas Asn197 and Asn25 mutations are distinctly remote from the colchicine-binding site. For details, see Liaw et al., in this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Spotlight on Molecular Profiling
Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines
Philip L. Lorenzi; Jenny Llamas; Michele Gunsior; Laurent Ozbun; William C. Reinhold; Sudhir Varma; Helen Ji; Hijoo Kim; Amy A. Hutchinson; Elise C. Kohn; Paul K. Goldsmith; Michael J. Birrer; John N. Weinstein
Review
Research Articles: Therapeutics, Targets, and Development
Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors
Leslie S. Kurtzberg; Traci Battle; Cecile Rouleau; Rebecca G. Bagley; Naoki Agata; Min Yao; Steven Schmid; Stephanie Roth; Jennifer Crawford; Roy Krumbholz; Reginald Ewesuedo; Xian-Jie Yu; Fei Wang; Edmond J. LaVoie; Beverly A. Teicher
Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts
Jay Sarup; Pei Jin; Lisa Turin; Xiaomei Bai; Malgorzata Beryt; Cathleen Brdlik; Jeffrey N. Higaki; Brett Jorgensen; Francis W. Lau; Peter Lindley; Jim Liu; Irene Ni; James Rozzelle; Rajendra Kumari; Susan A. Watson; Juan Zhang; H. Michael Shepard
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
Scott Ackler; Yu Xiao; Michael J. Mitten; Kelly Foster; Anatol Oleksijew; Marion Refici; Sally Schlessinger; Baole Wang; Sanjay R. Chemburkar; Joy Bauch; Christin Tse; David J. Frost; Stephen W. Fesik; Saul H. Rosenberg; Steven W. Elmore; Alex R. Shoemaker
Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer
Dongweon Song; Raghothama Chaerkady; Aik Choon Tan; Elena García-García; Anuradha Nalli; Ana Suárez-Gauthier; Fernando López-Ríos; Xian Feng Zhang; Anna Solomon; Jeffrey Tong; Margaret Read; Christian Fritz; Antonio Jimeno; Akhilesh Pandey; Manuel Hidalgo
Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-κB pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis
Ajaikumar B. Kunnumakkara; Haruyo Ichikawa; Preetha Anand; Chiramel J. Mohankumar; Padmanabhan S. Hema; Mangalam S. Nair; Bharat B. Aggarwal
Curcumin suppresses constitutive activation of nuclear factor-κB and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines
Azhar R. Hussain; Maqbool Ahmed; Naif A. Al-Jomah; Asma S. Khan; Pulicat Manogaran; Mehar Sultana; Jehad Abubaker; Leonidas C. Platanias; Khawla S. Al-Kuraya; Shahab Uddin
Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism
Sonia Priego; Fatima Feddi; Paula Ferrer; Salvador Mena; María Benlloch; Angel Ortega; Julian Carretero; Elena Obrador; Miguel Asensi; José M. Estrela
Therapeutic efficacy of soluble receptor activator of nuclear factor-κB-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma
François Lamoureux; Gaëlle Picarda; Julie Rousseau; Clothilde Gourden; Séverine Battaglia; Céline Charrier; Bruno Pitard; Dominique Heymann; Françoise Rédini
Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab′) fragments
Jie Gao; Geng Kou; Huaiwen Chen; Hao Wang; Bohua Li; Ying Lu; Dapeng Zhang; Shuhui Wang; Sheng Hou; Weizhu Qian; Jianxin Dai; Jian Zhao; Yanqiang Zhong; Yajun Guo
Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition
Hendrik Fischer; Ninon Taylor; Sigrid Allerstorfer; Michael Grusch; Gudrun Sonvilla; Klaus Holzmann; Ulrike Setinek; Leonilla Elbling; Heidelinde Cantonati; Bettina Grasl-Kraupp; Christine Gauglhofer; Brigitte Marian; Michael Micksche; Walter Berger
Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma
Cathy A. Payne; Sanaz Maleki; Marinella Messina; Maree G. O'Sullivan; Glenn Stone; Nathan R. Hall; Jonathon F. Parkinson; Helen R. Wheeler; Raymond J. Cook; Michael T. Biggs; Nicholas S. Little; Charles Teo; Bruce G. Robinson; Kerrie L. McDonald
Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using β-human choriogonadotropin secreting tumor cell lines
Giulio Francia; Urban Emmenegger; Christina R. Lee; Yuval Shaked; Christopher Folkins; Miriam Mossoba; Jeffrey A. Medin; Shan Man; Zhenping Zhu; Larry Witte; Robert S. Kerbel
Advertisement